We just received data on a new analyst forecast for $BAC. Christopher McGratty from Keefe, Bruyette & Woods set a price target of 63.0 for BAC.
To track analyst ratings and price targets for $BAC, check out Quiver Quantitative's $BAC forecast page.
Should you buy $BAC?
Some analysts are better than others. To view the past performance of Keefe, Bruyette & Woods, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$BAC Price Targets
Multiple analysts have issued price targets for $BAC recently. We have seen 13 analysts offer price targets for $BAC in the last 6 months, with a median target of $62.0.
Here are some recent targets:
- Christopher McGratty from Keefe, Bruyette & Woods set a target price of $63.0 on 01/15/2026
- An analyst from CICC set a target price of $62.0 on 01/14/2026
- Steven Alexopoulos from TD Cowen set a target price of $66.0 on 01/07/2026
- John McDonald from Truist Securities set a target price of $62.0 on 01/06/2026
- Richard Ramsden from Goldman Sachs set a target price of $64.0 on 01/06/2026
- Jason Goldberg from Barclays set a target price of $71.0 on 01/05/2026
- Betsy Graseck from Morgan Stanley set a target price of $68.0 on 12/12/2025
$BAC Insider Trading Activity
$BAC insiders have traded $BAC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BAC stock by insiders over the last 6 months:
- JAMES P DEMARE (President, Global Markets) sold 148,391 shares for an estimated $6,761,732
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BAC Revenue
$BAC had revenues of $28.4B in Q4 2025. This is an increase of 11.91% from the same period in the prior year.
You can track BAC financials on Quiver Quantitative's BAC stock page.
$BAC Congressional Stock Trading
Members of Congress have traded $BAC stock 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $BAC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/13, 08/14.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BAC Hedge Fund Activity
We have seen 1,596 institutional investors add shares of $BAC stock to their portfolio, and 1,406 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 86,751,929 shares (+1381.1%) to their portfolio in Q3 2025, for an estimated $4,475,532,017
- BERKSHIRE HATHAWAY INC removed 37,197,363 shares (-6.1%) from their portfolio in Q3 2025, for an estimated $1,919,011,957
- BLACKROCK, INC. added 19,941,314 shares (+3.9%) to their portfolio in Q3 2025, for an estimated $1,028,772,389
- VIKING GLOBAL INVESTORS LP removed 19,746,682 shares (-63.2%) from their portfolio in Q3 2025, for an estimated $1,018,731,324
- PRICE T ROWE ASSOCIATES INC /MD/ added 16,745,195 shares (+16.3%) to their portfolio in Q3 2025, for an estimated $863,884,610
- CITIGROUP INC added 14,678,720 shares (+37.9%) to their portfolio in Q3 2025, for an estimated $757,275,164
- CAPITAL WORLD INVESTORS added 14,275,810 shares (+11.0%) to their portfolio in Q3 2025, for an estimated $736,489,037
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
